EL.En. S.p.A.
EL.En. S.p.A. (ELEAF) Stock Competitors & Peer Comparison
See (ELEAF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ELEAF | $12.52 | +0.00% | 1B | 14.07 | $0.89 | +2.05% |
| SMMNY | $28.09 | +1.78% | 125.8B | 25.04 | $1.12 | +1.86% |
| SEMHF | $56.46 | +0.82% | 63.7B | 25.26 | $2.25 | +1.74% |
| RYLPF | $27.08 | -1.85% | 25.7B | 142.53 | $0.19 | +3.51% |
| SONVY | $58.05 | +1.89% | 17.3B | 25.95 | $2.24 | +1.85% |
| SONVF | $290.28 | +1.82% | 17.3B | 25.92 | $11.20 | +1.87% |
| SNNUF | $17.30 | +0.00% | 15.1B | 30.89 | $0.56 | +2.17% |
| CHEOY | $97.97 | +0.91% | 12.9B | 51.28 | $1.92 | +1.42% |
| CHEOF | $183.04 | +0.00% | 12B | 47.67 | $3.84 | +1.51% |
| WILYY | $18.99 | +0.00% | 8.5B | 19.58 | $0.97 | N/A |
Stock Comparison
ELEAF vs SMMNY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SMMNY has a market cap of 125.8B. Regarding current trading prices, ELEAF is priced at $12.52, while SMMNY trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SMMNY's P/E ratio is 25.04. In terms of profitability, ELEAF's ROE is +0.15%, compared to SMMNY's ROE of +0.12%. Regarding short-term risk, ELEAF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SMMNY's competition here
ELEAF vs SEMHF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SEMHF has a market cap of 63.7B. Regarding current trading prices, ELEAF is priced at $12.52, while SEMHF trades at $56.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SEMHF's P/E ratio is 25.26. In terms of profitability, ELEAF's ROE is +0.15%, compared to SEMHF's ROE of +0.12%. Regarding short-term risk, ELEAF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SEMHF's competition here
ELEAF vs RYLPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, RYLPF has a market cap of 25.7B. Regarding current trading prices, ELEAF is priced at $12.52, while RYLPF trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas RYLPF's P/E ratio is 142.53. In terms of profitability, ELEAF's ROE is +0.15%, compared to RYLPF's ROE of +0.01%. Regarding short-term risk, ELEAF is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check RYLPF's competition here
ELEAF vs SONVY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SONVY has a market cap of 17.3B. Regarding current trading prices, ELEAF is priced at $12.52, while SONVY trades at $58.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SONVY's P/E ratio is 25.95. In terms of profitability, ELEAF's ROE is +0.15%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, ELEAF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SONVY's competition here
ELEAF vs SONVF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SONVF has a market cap of 17.3B. Regarding current trading prices, ELEAF is priced at $12.52, while SONVF trades at $290.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SONVF's P/E ratio is 25.92. In terms of profitability, ELEAF's ROE is +0.15%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, ELEAF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check SONVF's competition here
ELEAF vs SNNUF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SNNUF has a market cap of 15.1B. Regarding current trading prices, ELEAF is priced at $12.52, while SNNUF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SNNUF's P/E ratio is 30.89. In terms of profitability, ELEAF's ROE is +0.15%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, ELEAF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SNNUF's competition here
ELEAF vs CHEOY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CHEOY has a market cap of 12.9B. Regarding current trading prices, ELEAF is priced at $12.52, while CHEOY trades at $97.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CHEOY's P/E ratio is 51.28. In terms of profitability, ELEAF's ROE is +0.15%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, ELEAF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CHEOY's competition here
ELEAF vs CHEOF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CHEOF has a market cap of 12B. Regarding current trading prices, ELEAF is priced at $12.52, while CHEOF trades at $183.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CHEOF's P/E ratio is 47.67. In terms of profitability, ELEAF's ROE is +0.15%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, ELEAF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CHEOF's competition here
ELEAF vs WILYY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, WILYY has a market cap of 8.5B. Regarding current trading prices, ELEAF is priced at $12.52, while WILYY trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas WILYY's P/E ratio is 19.58. In terms of profitability, ELEAF's ROE is +0.15%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, ELEAF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check WILYY's competition here
ELEAF vs WILLF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, WILLF has a market cap of 8.2B. Regarding current trading prices, ELEAF is priced at $12.52, while WILLF trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas WILLF's P/E ratio is 20.69. In terms of profitability, ELEAF's ROE is +0.15%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, ELEAF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check WILLF's competition here
ELEAF vs GNGBY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, GNGBY has a market cap of 6B. Regarding current trading prices, ELEAF is priced at $12.52, while GNGBY trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas GNGBY's P/E ratio is 38.39. In terms of profitability, ELEAF's ROE is +0.15%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, ELEAF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check GNGBY's competition here
ELEAF vs GNGBF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, GNGBF has a market cap of 5.7B. Regarding current trading prices, ELEAF is priced at $12.52, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas GNGBF's P/E ratio is 36.84. In terms of profitability, ELEAF's ROE is +0.15%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, ELEAF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check GNGBF's competition here
ELEAF vs AMBBY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, ELEAF is priced at $12.52, while AMBBY trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas AMBBY's P/E ratio is 72.05. In terms of profitability, ELEAF's ROE is +0.15%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, ELEAF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check AMBBY's competition here
ELEAF vs AMBFF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, AMBFF has a market cap of 4.1B. Regarding current trading prices, ELEAF is priced at $12.52, while AMBFF trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas AMBFF's P/E ratio is 72.90. In terms of profitability, ELEAF's ROE is +0.15%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, ELEAF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check AMBFF's competition here
ELEAF vs NHNKY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, ELEAF is priced at $12.52, while NHNKY trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas NHNKY's P/E ratio is 19.30. In terms of profitability, ELEAF's ROE is +0.15%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, ELEAF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check NHNKY's competition here
ELEAF vs MCRPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, MCRPF has a market cap of 3.3B. Regarding current trading prices, ELEAF is priced at $12.52, while MCRPF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas MCRPF's P/E ratio is -15.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, ELEAF is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check MCRPF's competition here
ELEAF vs GNNDY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, GNNDY has a market cap of 2.7B. Regarding current trading prices, ELEAF is priced at $12.52, while GNNDY trades at $56.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas GNNDY's P/E ratio is 21.64. In terms of profitability, ELEAF's ROE is +0.15%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, ELEAF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check GNNDY's competition here
ELEAF vs GGNDF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, GGNDF has a market cap of 2.6B. Regarding current trading prices, ELEAF is priced at $12.52, while GGNDF trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas GGNDF's P/E ratio is 20.56. In terms of profitability, ELEAF's ROE is +0.15%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, ELEAF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check GGNDF's competition here
ELEAF vs NHNKF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, ELEAF is priced at $12.52, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, ELEAF's ROE is +0.15%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, ELEAF is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check NHNKF's competition here
ELEAF vs OSSFF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, OSSFF has a market cap of 2B. Regarding current trading prices, ELEAF is priced at $12.52, while OSSFF trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas OSSFF's P/E ratio is 28.24. In terms of profitability, ELEAF's ROE is +0.15%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, ELEAF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check OSSFF's competition here
ELEAF vs STSEY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, ELEAF is priced at $12.52, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas STSEY's P/E ratio is 39.41. In terms of profitability, ELEAF's ROE is +0.15%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, ELEAF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check STSEY's competition here
ELEAF vs VTRLY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, ELEAF is priced at $12.52, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas VTRLY's P/E ratio is 42.80. In terms of profitability, ELEAF's ROE is +0.15%, compared to VTRLY's ROE of +0.03%. Regarding short-term risk, ELEAF is less volatile compared to VTRLY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check VTRLY's competition here
ELEAF vs DWRKF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, ELEAF is priced at $12.52, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, ELEAF's ROE is +0.15%, compared to DWRKF's ROE of N/A. Regarding short-term risk, ELEAF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check DWRKF's competition here
ELEAF vs OSSUY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, ELEAF is priced at $12.52, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, ELEAF's ROE is +0.15%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, ELEAF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check OSSUY's competition here
ELEAF vs MEDGF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, ELEAF is priced at $12.52, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, ELEAF's ROE is +0.15%, compared to MEDGF's ROE of +0.21%. Regarding short-term risk, ELEAF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check MEDGF's competition here
ELEAF vs DRWKF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, ELEAF is priced at $12.52, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, ELEAF's ROE is +0.15%, compared to DRWKF's ROE of +0.07%. Regarding short-term risk, ELEAF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check DRWKF's competition here
ELEAF vs DGWPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DGWPF has a market cap of 1.1B. Regarding current trading prices, ELEAF is priced at $12.52, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DGWPF's P/E ratio is 9.24. In terms of profitability, ELEAF's ROE is +0.15%, compared to DGWPF's ROE of +0.07%. Regarding short-term risk, ELEAF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check DGWPF's competition here
ELEAF vs LFTSF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, ELEAF is priced at $12.52, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, ELEAF's ROE is +0.15%, compared to LFTSF's ROE of +0.06%. Regarding short-term risk, ELEAF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check LFTSF's competition here
ELEAF vs MDRSF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, ELEAF is priced at $12.52, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, ELEAF's ROE is +0.15%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, ELEAF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check MDRSF's competition here
ELEAF vs XVIPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, XVIPF has a market cap of 646.9M. Regarding current trading prices, ELEAF is priced at $12.52, while XVIPF trades at $20.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas XVIPF's P/E ratio is 55.50. In terms of profitability, ELEAF's ROE is +0.15%, compared to XVIPF's ROE of +0.05%. Regarding short-term risk, ELEAF is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check XVIPF's competition here
ELEAF vs AVMR Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, ELEAF is priced at $12.52, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas AVMR's P/E ratio is -18.34. In terms of profitability, ELEAF's ROE is +0.15%, compared to AVMR's ROE of -0.92%. Regarding short-term risk, ELEAF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check AVMR's competition here
ELEAF vs CALZF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CALZF has a market cap of 475.6M. Regarding current trading prices, ELEAF is priced at $12.52, while CALZF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CALZF's P/E ratio is 68.84. In terms of profitability, ELEAF's ROE is +0.15%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, ELEAF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check CALZF's competition here
ELEAF vs CLVSF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, ELEAF is priced at $12.52, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, ELEAF's ROE is +0.15%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, ELEAF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CLVSF's competition here
ELEAF vs IOBCF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, IOBCF has a market cap of 388.2M. Regarding current trading prices, ELEAF is priced at $12.52, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas IOBCF's P/E ratio is 35.81. In terms of profitability, ELEAF's ROE is +0.15%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, ELEAF is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check IOBCF's competition here
ELEAF vs CSSPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CSSPF has a market cap of 384.4M. Regarding current trading prices, ELEAF is priced at $12.52, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to CSSPF's ROE of +0.05%. Regarding short-term risk, ELEAF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CSSPF's competition here
ELEAF vs HYBT Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, ELEAF is priced at $12.52, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas HYBT's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to HYBT's ROE of +0.00%. Regarding short-term risk, ELEAF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check HYBT's competition here
ELEAF vs EAPIF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, EAPIF has a market cap of 293.9M. Regarding current trading prices, ELEAF is priced at $12.52, while EAPIF trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas EAPIF's P/E ratio is -2.02. In terms of profitability, ELEAF's ROE is +0.15%, compared to EAPIF's ROE of -0.14%. Regarding short-term risk, ELEAF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check EAPIF's competition here
ELEAF vs HTLZF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, ELEAF is priced at $12.52, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, ELEAF's ROE is +0.15%, compared to HTLZF's ROE of -0.04%. Regarding short-term risk, ELEAF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check HTLZF's competition here
ELEAF vs CYBQY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CYBQY has a market cap of 238.1M. Regarding current trading prices, ELEAF is priced at $12.52, while CYBQY trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CYBQY's P/E ratio is -66.75. In terms of profitability, ELEAF's ROE is +0.15%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, ELEAF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CYBQY's competition here
ELEAF vs BCCOY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, BCCOY has a market cap of 225.8M. Regarding current trading prices, ELEAF is priced at $12.52, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas BCCOY's P/E ratio is -5.33. In terms of profitability, ELEAF's ROE is +0.15%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, ELEAF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check BCCOY's competition here
ELEAF vs BRSYF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, BRSYF has a market cap of 207.5M. Regarding current trading prices, ELEAF is priced at $12.52, while BRSYF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas BRSYF's P/E ratio is 39.21. In terms of profitability, ELEAF's ROE is +0.15%, compared to BRSYF's ROE of +0.09%. Regarding short-term risk, ELEAF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check BRSYF's competition here
ELEAF vs IMPZY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, IMPZY has a market cap of 198.4M. Regarding current trading prices, ELEAF is priced at $12.52, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, ELEAF's ROE is +0.15%, compared to IMPZY's ROE of -15.79%. Regarding short-term risk, ELEAF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check IMPZY's competition here
ELEAF vs CLLKF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CLLKF has a market cap of 196.2M. Regarding current trading prices, ELEAF is priced at $12.52, while CLLKF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CLLKF's P/E ratio is -4.73. In terms of profitability, ELEAF's ROE is +0.15%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, ELEAF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check CLLKF's competition here
ELEAF vs PXMBF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, PXMBF has a market cap of 182.1M. Regarding current trading prices, ELEAF is priced at $12.52, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, ELEAF's ROE is +0.15%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, ELEAF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check PXMBF's competition here
ELEAF vs DTXMF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, ELEAF is priced at $12.52, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, ELEAF's ROE is +0.15%, compared to DTXMF's ROE of -0.45%. Regarding short-term risk, ELEAF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check DTXMF's competition here
ELEAF vs EKDHF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, EKDHF has a market cap of 175.1M. Regarding current trading prices, ELEAF is priced at $12.52, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas EKDHF's P/E ratio is 19.50. In terms of profitability, ELEAF's ROE is +0.15%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, ELEAF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check EKDHF's competition here
ELEAF vs CYBQF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CYBQF has a market cap of 172.8M. Regarding current trading prices, ELEAF is priced at $12.52, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CYBQF's P/E ratio is -64.75. In terms of profitability, ELEAF's ROE is +0.15%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, ELEAF is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CYBQF's competition here
ELEAF vs DMTRF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DMTRF has a market cap of 168.4M. Regarding current trading prices, ELEAF is priced at $12.52, while DMTRF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DMTRF's P/E ratio is -8.82. In terms of profitability, ELEAF's ROE is +0.15%, compared to DMTRF's ROE of -0.65%. Regarding short-term risk, ELEAF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check DMTRF's competition here
ELEAF vs FDMDF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, FDMDF has a market cap of 136.3M. Regarding current trading prices, ELEAF is priced at $12.52, while FDMDF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas FDMDF's P/E ratio is -4.18. In terms of profitability, ELEAF's ROE is +0.15%, compared to FDMDF's ROE of -0.51%. Regarding short-term risk, ELEAF is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check FDMDF's competition here
ELEAF vs AVHHL Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, AVHHL has a market cap of 128.4M. Regarding current trading prices, ELEAF is priced at $12.52, while AVHHL trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas AVHHL's P/E ratio is -2.08. In terms of profitability, ELEAF's ROE is +0.15%, compared to AVHHL's ROE of +279.91%. Regarding short-term risk, ELEAF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check AVHHL's competition here
ELEAF vs AMEUF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, ELEAF is priced at $12.52, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, ELEAF's ROE is +0.15%, compared to AMEUF's ROE of -2.19%. Regarding short-term risk, ELEAF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check AMEUF's competition here
ELEAF vs SNZZF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SNZZF has a market cap of 110.9M. Regarding current trading prices, ELEAF is priced at $12.52, while SNZZF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SNZZF's P/E ratio is -7.05. In terms of profitability, ELEAF's ROE is +0.15%, compared to SNZZF's ROE of -0.39%. Regarding short-term risk, ELEAF is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SNZZF's competition here
ELEAF vs VMTHF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, ELEAF is priced at $12.52, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, ELEAF's ROE is +0.15%, compared to VMTHF's ROE of -0.29%. Regarding short-term risk, ELEAF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check VMTHF's competition here
ELEAF vs JMDMF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, ELEAF is priced at $12.52, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, ELEAF's ROE is +0.15%, compared to JMDMF's ROE of N/A. Regarding short-term risk, ELEAF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check JMDMF's competition here
ELEAF vs SOMNF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, SOMNF has a market cap of 96M. Regarding current trading prices, ELEAF is priced at $12.52, while SOMNF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas SOMNF's P/E ratio is -14.67. In terms of profitability, ELEAF's ROE is +0.15%, compared to SOMNF's ROE of -0.20%. Regarding short-term risk, ELEAF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check SOMNF's competition here
ELEAF vs RSHUF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, ELEAF is priced at $12.52, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, ELEAF's ROE is +0.15%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, ELEAF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check RSHUF's competition here
ELEAF vs CKMTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, ELEAF is priced at $12.52, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, ELEAF's ROE is +0.15%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, ELEAF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check CKMTF's competition here
ELEAF vs IPDQF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, IPDQF has a market cap of 50.7M. Regarding current trading prices, ELEAF is priced at $12.52, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas IPDQF's P/E ratio is -2.50. In terms of profitability, ELEAF's ROE is +0.15%, compared to IPDQF's ROE of -0.39%. Regarding short-term risk, ELEAF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check IPDQF's competition here
ELEAF vs BLOZF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, BLOZF has a market cap of 49M. Regarding current trading prices, ELEAF is priced at $12.52, while BLOZF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas BLOZF's P/E ratio is -21.28. In terms of profitability, ELEAF's ROE is +0.15%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, ELEAF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check BLOZF's competition here
ELEAF vs RDGL Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, RDGL has a market cap of 48.1M. Regarding current trading prices, ELEAF is priced at $12.52, while RDGL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas RDGL's P/E ratio is -10.60. In terms of profitability, ELEAF's ROE is +0.15%, compared to RDGL's ROE of -1.45%. Regarding short-term risk, ELEAF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check RDGL's competition here
ELEAF vs BRNHF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, BRNHF has a market cap of 42.3M. Regarding current trading prices, ELEAF is priced at $12.52, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, ELEAF's ROE is +0.15%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, ELEAF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check BRNHF's competition here
ELEAF vs TLTFF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, TLTFF has a market cap of 40.9M. Regarding current trading prices, ELEAF is priced at $12.52, while TLTFF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas TLTFF's P/E ratio is -16.29. In terms of profitability, ELEAF's ROE is +0.15%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, ELEAF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check TLTFF's competition here
ELEAF vs NVYTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, NVYTF has a market cap of 35.4M. Regarding current trading prices, ELEAF is priced at $12.52, while NVYTF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas NVYTF's P/E ratio is -0.68. In terms of profitability, ELEAF's ROE is +0.15%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, ELEAF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check NVYTF's competition here
ELEAF vs ELXMF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ELXMF has a market cap of 28.5M. Regarding current trading prices, ELEAF is priced at $12.52, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to ELXMF's ROE of -0.39%. Regarding short-term risk, ELEAF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check ELXMF's competition here
ELEAF vs MKEAF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, ELEAF is priced at $12.52, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, ELEAF's ROE is +0.15%, compared to MKEAF's ROE of +0.47%. Regarding short-term risk, ELEAF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check MKEAF's competition here
ELEAF vs KBBTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, ELEAF is priced at $12.52, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, ELEAF's ROE is +0.15%, compared to KBBTF's ROE of N/A. Regarding short-term risk, ELEAF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check KBBTF's competition here
ELEAF vs EMITF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, EMITF has a market cap of 23.9M. Regarding current trading prices, ELEAF is priced at $12.52, while EMITF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas EMITF's P/E ratio is -12.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to EMITF's ROE of -0.08%. Regarding short-term risk, ELEAF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check EMITF's competition here
ELEAF vs POSC Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, POSC has a market cap of 22.7M. Regarding current trading prices, ELEAF is priced at $12.52, while POSC trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas POSC's P/E ratio is 0.32. In terms of profitability, ELEAF's ROE is +0.15%, compared to POSC's ROE of +9.25%. Regarding short-term risk, ELEAF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check POSC's competition here
ELEAF vs GTHP Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, GTHP has a market cap of 20.6M. Regarding current trading prices, ELEAF is priced at $12.52, while GTHP trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas GTHP's P/E ratio is -5.23. In terms of profitability, ELEAF's ROE is +0.15%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, ELEAF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check GTHP's competition here
ELEAF vs PYNKF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, PYNKF has a market cap of 19.2M. Regarding current trading prices, ELEAF is priced at $12.52, while PYNKF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas PYNKF's P/E ratio is -0.80. In terms of profitability, ELEAF's ROE is +0.15%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, ELEAF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check PYNKF's competition here
ELEAF vs DIZTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, ELEAF is priced at $12.52, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, ELEAF's ROE is +0.15%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, ELEAF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check DIZTF's competition here
ELEAF vs ASAPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ASAPF has a market cap of 15M. Regarding current trading prices, ELEAF is priced at $12.52, while ASAPF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ASAPF's P/E ratio is -19.25. In terms of profitability, ELEAF's ROE is +0.15%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, ELEAF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check ASAPF's competition here
ELEAF vs MDXHF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, MDXHF has a market cap of 14.2M. Regarding current trading prices, ELEAF is priced at $12.52, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, ELEAF's ROE is +0.15%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, ELEAF is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check MDXHF's competition here
ELEAF vs TMDIF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, ELEAF is priced at $12.52, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, ELEAF's ROE is +0.15%, compared to TMDIF's ROE of -0.57%. Regarding short-term risk, ELEAF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check TMDIF's competition here
ELEAF vs VPTDF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, VPTDF has a market cap of 13.6M. Regarding current trading prices, ELEAF is priced at $12.52, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas VPTDF's P/E ratio is -4.07. In terms of profitability, ELEAF's ROE is +0.15%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, ELEAF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check VPTDF's competition here
ELEAF vs PLLWF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, ELEAF is priced at $12.52, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, ELEAF's ROE is +0.15%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, ELEAF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check PLLWF's competition here
ELEAF vs IMEXF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, ELEAF is priced at $12.52, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas IMEXF's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, ELEAF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check IMEXF's competition here
ELEAF vs ATBPF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, ELEAF is priced at $12.52, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, ELEAF's ROE is +0.15%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, ELEAF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check ATBPF's competition here
ELEAF vs LXXGF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, ELEAF is priced at $12.52, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, ELEAF's ROE is +0.15%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, ELEAF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check LXXGF's competition here
ELEAF vs NGMDF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, NGMDF has a market cap of 9.3M. Regarding current trading prices, ELEAF is priced at $12.52, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas NGMDF's P/E ratio is -4.08. In terms of profitability, ELEAF's ROE is +0.15%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, ELEAF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check NGMDF's competition here
ELEAF vs FZMD Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, FZMD has a market cap of 6.4M. Regarding current trading prices, ELEAF is priced at $12.52, while FZMD trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas FZMD's P/E ratio is 1.44. In terms of profitability, ELEAF's ROE is +0.15%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, ELEAF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check FZMD's competition here
ELEAF vs RMSL Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, RMSL has a market cap of 6.1M. Regarding current trading prices, ELEAF is priced at $12.52, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas RMSL's P/E ratio is 0.40. In terms of profitability, ELEAF's ROE is +0.15%, compared to RMSL's ROE of -2.86%. Regarding short-term risk, ELEAF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check RMSL's competition here
ELEAF vs QLIS Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, ELEAF is priced at $12.52, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas QLIS's P/E ratio is 2.22. In terms of profitability, ELEAF's ROE is +0.15%, compared to QLIS's ROE of -0.95%. Regarding short-term risk, ELEAF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check QLIS's competition here
ELEAF vs RHNMF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, ELEAF is priced at $12.52, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, ELEAF's ROE is +0.15%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, ELEAF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check RHNMF's competition here
ELEAF vs ODYY Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ODYY has a market cap of 4.6M. Regarding current trading prices, ELEAF is priced at $12.52, while ODYY trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ODYY's P/E ratio is -0.32. In terms of profitability, ELEAF's ROE is +0.15%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, ELEAF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check ODYY's competition here
ELEAF vs ALRTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ALRTF has a market cap of 4.5M. Regarding current trading prices, ELEAF is priced at $12.52, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ALRTF's P/E ratio is -0.24. In terms of profitability, ELEAF's ROE is +0.15%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, ELEAF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check ALRTF's competition here
ELEAF vs VYCO Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, VYCO has a market cap of 4.3M. Regarding current trading prices, ELEAF is priced at $12.52, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas VYCO's P/E ratio is -13.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, ELEAF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check VYCO's competition here
ELEAF vs LBLTF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, ELEAF is priced at $12.52, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, ELEAF's ROE is +0.15%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, ELEAF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check LBLTF's competition here
ELEAF vs ADMT Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ADMT has a market cap of 4.1M. Regarding current trading prices, ELEAF is priced at $12.52, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ADMT's P/E ratio is -6.00. In terms of profitability, ELEAF's ROE is +0.15%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, ELEAF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check ADMT's competition here
ELEAF vs PMEDF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, PMEDF has a market cap of 3.5M. Regarding current trading prices, ELEAF is priced at $12.52, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas PMEDF's P/E ratio is -1.81. In terms of profitability, ELEAF's ROE is +0.15%, compared to PMEDF's ROE of +0.80%. Regarding short-term risk, ELEAF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check PMEDF's competition here
ELEAF vs VANIW Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, ELEAF is priced at $12.52, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas VANIW's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to VANIW's ROE of -1.95%. Regarding short-term risk, ELEAF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check VANIW's competition here
ELEAF vs BIEL Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, BIEL has a market cap of 2.7M. Regarding current trading prices, ELEAF is priced at $12.52, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas BIEL's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, ELEAF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check BIEL's competition here
ELEAF vs NUMD Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, NUMD has a market cap of 2.7M. Regarding current trading prices, ELEAF is priced at $12.52, while NUMD trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas NUMD's P/E ratio is 3.20. In terms of profitability, ELEAF's ROE is +0.15%, compared to NUMD's ROE of +0.27%. Regarding short-term risk, ELEAF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check NUMD's competition here
ELEAF vs TBRIF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, TBRIF has a market cap of 2.6M. Regarding current trading prices, ELEAF is priced at $12.52, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas TBRIF's P/E ratio is -0.75. In terms of profitability, ELEAF's ROE is +0.15%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, ELEAF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check TBRIF's competition here
ELEAF vs USAQ Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, USAQ has a market cap of 2.1M. Regarding current trading prices, ELEAF is priced at $12.52, while USAQ trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas USAQ's P/E ratio is -4.75. In terms of profitability, ELEAF's ROE is +0.15%, compared to USAQ's ROE of +0.68%. Regarding short-term risk, ELEAF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check USAQ's competition here
ELEAF vs ESMC Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, ESMC has a market cap of 2M. Regarding current trading prices, ELEAF is priced at $12.52, while ESMC trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas ESMC's P/E ratio is 5.40. In terms of profitability, ELEAF's ROE is +0.15%, compared to ESMC's ROE of +0.31%. Regarding short-term risk, ELEAF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check ESMC's competition here
ELEAF vs CRRVF Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, ELEAF is priced at $12.52, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CRRVF's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, ELEAF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for ELEAF.Check CRRVF's competition here
ELEAF vs LLBO Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, LLBO has a market cap of 1.3M. Regarding current trading prices, ELEAF is priced at $12.52, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas LLBO's P/E ratio is N/A. In terms of profitability, ELEAF's ROE is +0.15%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, ELEAF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check LLBO's competition here
ELEAF vs CYDX Comparison August 2025
ELEAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELEAF stands at 1B. In comparison, CYDX has a market cap of 1.3M. Regarding current trading prices, ELEAF is priced at $12.52, while CYDX trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELEAF currently has a P/E ratio of 14.07, whereas CYDX's P/E ratio is 0.33. In terms of profitability, ELEAF's ROE is +0.15%, compared to CYDX's ROE of +0.17%. Regarding short-term risk, ELEAF is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for ELEAF.Check CYDX's competition here